In the present study, we investigated the role of PTTG1 in melanoma cell proliferation, invasiveness and response to the BRAF inhibitor (BRAFi) dabrafenib by using two pairs of syngeneic melanoma cell lines sensitive or with acquired resistance to the drug. The gene discussed is PTTG1; the disease is melanoma.